For Researchers

The proposal process

Proposals should consider each of the following priorities within project applications:

  • Population Health Perspective: Projects should look to address clinical behaviors or outcomes from a population health perspective. For instance, identifying potential proxies within clinical and claims data that can incorporate social determinants of health within their analytic plan. Use of de-identified external data to augment the provided data set is encouraged.
  • Predictive and Prescriptive: Ultimately, the goal of the project should not be to simply provide novel insights but to move findings within the healthcare system past predictive ability and into prescriptive actions.
  • Multidisciplinary Approach: Innovation stemming from multiple disciplines, able to bring a truly multidisciplinary approach and impact, will be prioritized in the review process.
  • Impact: All projects should identify an actionable impact. Possible impacts include actionable prescriptive algorithms and targeted population segmentations for quality improvement projects.

Proposal and project timeline

  • Proposal Information Webinar: Tuesday, Novemeber 6, 2018
  • Applications due: Friday, Dec. 7, 2018
  • Award notification and data release: January 2019
  • Data analysis phase: January 2019 – September 2019
  • Feasibility and validation phase: Begins August 2019

The data

Sanford is committed to the protection of our patient’s data. Datasets will be limited in nature, researchers and their associated academic institutions will be required to sign a Data Usage Agreement ensuring the highest level of protection surrounding released data.

The data comes from Sanford Health, one of the largest health care systems in the nation. Headquartered in the Dakotas, the system has received nearly $1 billion in gifts from philanthropist Denny Sanford. These gifts have allowed for several groundbreaking initiatives, including global children's clinics, genomic medicine and specialized centers researching cures for type 1 diabetes, breast cancer and other diseases.